Production of pathogen‐inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study-Reference-Cited by-同舟云学术

Production of pathogen‐inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study

Published:2002-02 Issue:2 Volume:42 Page:146-152
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

AuBuchon James P.¹²,Pickard Constance A.¹²,Herschel Louise H.¹²,Roger Jill C.¹²,Tracy James E.¹²,Purmal Andrei¹²,Chapman John¹²,Ackerman Samuel¹²,Beach Kathleen J.¹²

Affiliation:

1. From the Cell Labeling Laboratory, Department of Pathology, Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire

2. V.I. Technologies, Inc., Watertown, Massachusetts.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1537-2995.2002.00021.x

Reference16 articles.

1. Transfusion Medicine — Blood Transfusion

2. Transfusion medicine: an overview and update.;Ness PM;Clin Chem,2000

3. Virus inactivated single‐donor fresh plasma preparations.;Mohr H;Infusionsther Transfusionmed,1992

4. Solvent/detergent‐treated plasma: a virus‐inactivated substitute for fresh frozen plasma.;Horowitz B;Blood,1992

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral reduction of human blood by ultraviolet A‐photosensitized vitamin K5;Journal of Medical Virology;2021-05-31

2. Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage;Transfusion;2017-03-31

3. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries;BLOOD TRANSFUS-ITALY;2017

4. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood;Transfusion;2011-01-28

5. Developing pathogen reduction technologies for RBC suspensions;Vox Sanguinis;2010-12-22